Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-06-10 7:22 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Thompson Peter A. Director |
0 | $0 | 2,336,911 (Indirect) |
View |
Ownership |
2021-06-10 7:18 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
0 | $0 | 4,215,166 (Direct) |
View |
Ownership |
2021-06-10 7:15 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer |
0 | $0 | 338,183 (Direct) |
View |
Ownership |
2021-06-10 7:12 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Lichter Jay Director 10% Owner |
0 | $0 | 8,237,298 (Indirect) |
View |
Ownership |
2021-06-10 7:10 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Heller Stefan Director |
0 | $0 | 96,075 (Direct) |
View |
Ownership |
2021-06-10 7:06 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director |
0 | $0 | 162,687 (Direct) |
View |
Ownership |
2021-06-10 7:05 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 5,729,468 (Indirect) |
View |
Ownership |
2021-06-10 7:04 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director |
0 | $0 | 96,075 (Direct) |
View |
Ownership |
2021-06-10 7:02 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Campbell David Alan Chief Executive Officer |
0 | $0 | 2,276,612 (Direct) |
View |